Topic

Insurance Approval

A collection of 6650 issues

How to Get Oxervate (cenegermin) Covered by Aetna (CVS Health) in Virginia: Complete Prior Authorization and Appeal Guide

Answer Box: Getting Oxervate Covered by Aetna in Virginia Aetna (CVS Health) requires prior authorization for Oxervate (cenegermin) for neurotrophic keratitis. You'll need documented stage 2 or 3 disease (ICD-10 codes H16.231-H16.233), failure of artificial tears, and an ophthalmologist's prescription. Submit through CVS Caremark

Work With Your Doctor to Get Strimvelis Gene Therapy Approved by UnitedHealthcare in Michigan: Provider Partnership Guide

Answer Box: Your Path to Approval Getting Strimvelis (autologous CD34+ ADA-SCID gene therapy) approved by UnitedHealthcare in Michigan requires strong provider partnership. Your doctor must submit prior authorization with confirmed ADA enzyme deficiency (<1% normal), genetic testing, HSCT ineligibility documentation, and medical necessity letter citing life-threatening urgency. If denied,

How to Get Xywav (Ca/Mg/K/Na oxybates) Covered by Blue Cross Blue Shield in Washington: Complete Prior Authorization Guide

Answer Box: Getting Xywav Covered by Blue Cross Blue Shield in Washington Xywav (Ca/Mg/K/Na oxybates) requires prior authorization from Blue Cross Blue Shield plans in Washington, typically with step therapy requiring documented Xyrem failure. The fastest path: 1) Enroll in the XYWAV REMS program (same day), 2)

Blue Cross Blue Shield Florida's Coverage Criteria for Tepezza: What Counts as "Medically Necessary"?

Answer Box: Getting Tepezza Covered by Florida Blue BCBS Florida Blue requires prior authorization for Tepezza (teprotumumab) with specific thyroid eye disease criteria: active TED diagnosis, Clinical Activity Score documentation, euthyroid status, and ophthalmologist prescriber. Submit PA via Availity.com or call 1-877-719-2583. Coverage decisions are delegated to Prime Therapeutics.

How to Get Kesimpta (ofatumumab) Covered by Blue Cross Blue Shield of Michigan: Complete Prior Authorization and Appeal Guide

Answer Box: Getting Kesimpta Covered by BCBS Michigan Kesimpta (ofatumumab) is covered by Blue Cross Blue Shield of Michigan but requires prior authorization with step therapy documentation (typically 2+ failed MS therapies) and safety screening including hepatitis B testing. The fastest path: your neurologist submits PA through the BCBS Michigan

How to Get Idelvion (albutrepenonacog alfa; rFIX-FP) Covered by Cigna in Illinois: Complete Appeals Guide with Forms and Timelines

Getting Idelvion (albutrepenonacog alfa; rFIX-FP) covered by Cigna in Illinois requires prior authorization through Express Scripts/Accredo specialty pharmacy, with documentation of hemophilia B diagnosis (Factor IX ≤2%), negative inhibitor testing (<0.6 BU), and failure of standard Factor IX products. The fastest path: have your hematologist submit PA

How to Get Orfadin (nitisinone) Covered by Cigna in California: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Orfadin (nitisinone) Covered by Cigna in California Cigna requires prior authorization for Orfadin (nitisinone) with confirmed hereditary tyrosinemia type 1 diagnosis, metabolic specialist involvement, and dietary restriction plan. In California, if denied, you can appeal internally (30 days) then request Independent Medical Review through DMHC with 55%

How to Get Cabometyx (Cabozantinib) Covered by Blue Cross Blue Shield in Florida: Complete PA Guide with Appeal Forms and State Protections

Answer Box: Getting Cabometyx Covered by Blue Cross Blue Shield in Florida Cabometyx (cabozantinib) requires prior authorization from Blue Cross Blue Shield in Florida. For oncology indications, submit PA requests to New Century Health (not Prime Therapeutics) via Availity portal, CoverMyMeds, or fax. Florida law protects advanced metastatic cancer patients

How to Get Firazyr (icatibant) Covered by Cigna in Michigan: Prior Authorization, Appeals, and State Protections Guide

Answer Box: Getting Firazyr (icatibant) Covered by Cigna in Michigan Firazyr (icatibant) requires prior authorization from Cigna in Michigan, processed through Express Scripts/Accredo specialty pharmacy within 2 business days (24 hours expedited). Submit electronically via CoverMyMeds with HAE diagnosis (ICD-10 D84.1), prior attack documentation, and specialist confirmation. If

If Zanzalintinib (XL092) Isn't Approved by UnitedHealthcare in New Jersey: Formulary Alternatives & Exception Paths

Answer Box: Getting Zanzalintinib (XL092) Coverage in New Jersey Zanzalintinib (XL092) is investigational and typically denied by UnitedHealthcare outside clinical trials. Your fastest path: (1) Check trial eligibility at ClinicalTrials.gov—patients with ≤2 prior TKIs may qualify; (2) If ineligible, request medical exception through OptumRx for compassionate use with